BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Shang L, Ye X, Zhu G, Su H, Su Z, Chen B, Xiao K, Li L, Peng M, Peng T. Prognostic value of integrin variants and expression in post-operative patients with HBV-related hepatocellular carcinoma. Oncotarget 2017;8:76816-31. [PMID: 29100351 DOI: 10.18632/oncotarget.20161] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
Number Citing Articles
1 Shi X, Tu S, Zhu L. Risk characteristics with seven epithelial-mesenchymal transition-related genes are used to predict the prognosis of patients with hepatocellular carcinoma. J Gastrointest Oncol 2021;12:1884-94. [PMID: 34532136 DOI: 10.21037/jgo-21-394] [Reference Citation Analysis]
2 Gong YZ, Ruan GT, Liao XW, Wang XK, Liao C, Wang S, Gao F. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma. Oncol Rep 2019;42:923-36. [PMID: 31322253 DOI: 10.3892/or.2019.7216] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
3 Xiong C, Wang G, Bai D. A novel prognostic models for identifying the risk of hepatocellular carcinoma based on epithelial-mesenchymal transition-associated genes. Bioengineered 2020;11:1034-46. [PMID: 32951492 DOI: 10.1080/21655979.2020.1822715] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
4 Shyu Y, Huang T, Chien C, Yeh C, Lin C, Chien R. Diabetes poses a higher risk of hepatocellular carcinoma and mortality in patients with chronic hepatitis B: A population‐based cohort study. J Viral Hepat 2019;26:718-26. [DOI: 10.1111/jvh.13077] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]